Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
May 26  •  02:28PM ET
3.86
Dollar change
0.00
Percentage change
0.00
%
Index
-
P/E
-
EPS (ttm)
-0.60
Insider Own
16.12%
Shs Outstand
22.67M
Perf Week
-2.53%
Market Cap
87.50M
Forward P/E
-
EPS next Y
-0.16
Insider Trans
0.00%
Shs Float
14.53M
Perf Month
-11.87%
Enterprise Value
84.75M
PEG
-
EPS next Q
-0.12
Inst Own
9.82%
Perf Quarter
-17.87%
Income
-11.44M
P/S
2.49
EPS this Y
34.17%
Inst Trans
0.58%
Perf Half Y
-39.12%
Sales
35.16M
P/B
3.80
EPS next Y
58.86%
ROA
-31.71%
Perf YTD
-25.63%
Book/sh
1.02
P/C
4.56
EPS next 5Y
-
ROE
-103.29%
52W High
12.80 -69.84%
Perf Year
-38.66%
Cash/sh
0.85
P/FCF
-
EPS past 3/5Y
11.10% 2.26%
ROIC
-31.79%
52W Low
3.57 8.12%
Perf 3Y
-31.58%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
84.46% 144.37%
Gross Margin
59.50%
Volatility
6.01% 5.43%
Perf 5Y
-59.58%
Dividend TTM
-
EV/Sales
2.41
EPS Y/Y TTM
-18.62%
Oper. Margin
-16.19%
ATR (14)
0.22
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
2.44
Sales Y/Y TTM
26.90%
Profit Margin
-32.54%
RSI (14)
40.89
Dividend Gr. 3/5Y
- -
Current Ratio
2.96
EPS Q/Q
13.64%
SMA20
-4.11%
Beta
1.34
Payout
-
Debt/Eq
0.71
Sales Q/Q
8.23%
SMA50
-8.39%
Rel Volume
1.20
Prev Close
3.86
Employees
89
LT Debt/Eq
0.56
SMA200
-39.99%
Avg Volume
27.17K
Price
3.86
IPO
Mar 08, 2019
Option/Short
No / Yes
Trades
Volume
25,470
Change
0.00%
Date Action Analyst Rating Change Price Target Change
Feb-19-26Initiated Roth Capital Buy $10
May-05-25Initiated Craig Hallum Buy $15
Dec-18-24Initiated Maxim Group Buy $12
May-19-26 08:39AM
May-18-26 07:00AM
May-15-26 08:30AM
May-14-26 07:03PM
08:39AM
07:00AM Loading…
07:00AM
May-13-26 05:32PM
09:48AM
08:00AM
07:48AM
May-12-26 09:02AM
07:52AM
07:30AM
Apr-30-26 04:05PM
Apr-29-26 09:08AM
08:30AM Loading…
08:30AM
07:51AM
Apr-01-26 08:30AM
Mar-31-26 11:01PM
04:25PM
04:02PM
10:03AM
08:00AM
Mar-26-26 09:11AM
07:30AM
Mar-17-26 08:30AM
Mar-13-26 04:53PM
Mar-05-26 04:15PM
03:49PM
09:21AM
07:30AM Loading…
07:30AM
Mar-03-26 08:30AM
Jan-07-26 07:30AM
Dec-18-25 07:30AM
Dec-03-25 07:30AM
Nov-14-25 12:04AM
Nov-13-25 05:50PM
04:05PM
Nov-12-25 05:25PM
08:42AM
Nov-10-25 04:18PM
08:15AM
Nov-07-25 07:30AM
Nov-06-25 08:00PM
04:37PM
Nov-04-25 07:30AM
Nov-03-25 09:37PM
05:35PM
Oct-30-25 07:30AM
Sep-22-25 06:32AM
Sep-10-25 07:00AM
Sep-02-25 08:30AM
Aug-13-25 08:00AM
Aug-12-25 03:03AM
Aug-11-25 06:55PM
07:30AM
Aug-07-25 07:15PM
Aug-06-25 05:45PM
Aug-04-25 08:30AM
Jul-24-25 11:09AM
Jul-23-25 08:30AM
Jun-04-25 07:00AM
Jun-03-25 08:50AM
May-21-25 08:30AM
08:00AM
May-15-25 05:45PM
04:05PM
May-13-25 07:15AM
May-12-25 08:30AM
May-08-25 10:00AM
08:15AM
May-07-25 05:25PM
May-06-25 06:30PM
May-01-25 08:30AM
Apr-15-25 07:20AM
Apr-10-25 10:10AM
Mar-31-25 08:54PM
05:45PM
04:05PM
Mar-26-25 08:10AM
Mar-17-25 08:30AM
Mar-06-25 08:30AM
Mar-04-25 08:30AM
Feb-18-25 08:30AM
Feb-12-25 08:30AM
Jan-22-25 07:00AM
03:30AM
Jan-08-25 08:40AM
Dec-11-24 01:00AM
Dec-02-24 08:00AM
Nov-25-24 04:05PM
03:30AM
Nov-21-24 08:30AM
Nov-18-24 08:30AM
Nov-12-24 08:30AM
BioHarvest Sciences, Inc. develops bio-cell growth platform technology. The firm engages in botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions. It offers nutraceutical health and wellness products, which includes dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients. The company was founded on April 19, 2013 and is headquartered in Vancouver, Canada.
Co-FounderDr. Zaki Rakib Ph.D.
Co-FounderDr. Yoheved Hagay Ph.D.
Chief Operating OfficerDr. Ilana Belzer Ph.D.
VP of Investor Relations & SecretaryMr. David K. Ryan
Chief Financial OfficerMs. Bar Dichter